Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study

BACKGROUND: Xpert MTB/RIF (Xpert) was piloted in Kazakhstan to detect tuberculosis (TB) and rifampicin resistance (RR-)TB among individuals at risk of multidrug-resistant (MDR-) TB. This study assessed the performance of Xpert compared to conventional diagnostic methods, RR-TB case detection among v...

Descripción completa

Detalles Bibliográficos
Autores principales: van Kampen, Sanne Christine, Tursynbayeva, Aigul, Koptleuova, Aliya, Murzabekova, Zauresh, Bigalieva, Lyazzat, Aubakirova, Moldir, Pak, Svetlana, van den Hof, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504513/
https://www.ncbi.nlm.nih.gov/pubmed/26181578
http://dx.doi.org/10.1371/journal.pone.0132514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504513/
https://www.ncbi.nlm.nih.gov/pubmed/26181578
http://dx.doi.org/10.1371/journal.pone.0132514

Ejemplares similares